Cleansing Device for the Treatment of Scalp and Hair Conditions
Dandruff, Seborrheic Dermatitis, Hair Loss
About this trial
This is an interventional treatment trial for Dandruff
Eligibility Criteria
Inclusion Criteria:
- Participants must qualify for one of the following scalp conditions based on clinical opinion of a board-certified dermatologist: healthy scalp, dandruff, seborrheic dermatitis, or hair loss disease
All Women of Child Bearing Potential must indicate use of two of the following contraceptive methods. The WaterPik device uses an ultrasonic technology which includes ultrasound. Unnecessary ultrasound is not recommended for pregnant women.
- Combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation (oral, intravaginal, or transdermal)
- Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, or implantable)
- Intrauterine device (IUD)
- Intraurerine hormone-releasing system (IUS)
- Vasectomized partner
- Sexual abstinence
- Barrier method, such as a condom
Exclusion Criteria:
- Non-English speaking
- Exclusion related to pregnancy, lactation, or plans to become pregnant over the course of the study (based on self-report from the participant)
- Current clinical condition that, in the opinion of the site investigator, would interfere with adherence to study requirements
Sites / Locations
- University of MinnesotaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Arm 7
Arm 8
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Healthy Scalp and one treatment
Healthy Scalp and three treatments
Dandruff and one treatment
Dandruff and three treatments
Hair loss disease and one treatment
Seborrheic Dermatitis with one treatment
Seborrheic Dermatitis and three treatments
Hair loss disease and three treatments
Participants with healthy scalps who will receive one treatment with the device and complete one in-person follow-up.
Participants with healthy scalps who will receive three treatments with the device and complete one in-person follow-up.
Participants with dandruff who will receive one treatment with the device and complete one in-person follow-up.
Participants with dandruff who will receive three treatments with the device and complete one in-person follow-up.
Participants with hair loss disease who will receive one treatment with the device and complete one in-person follow-up.
Participants with seborrheic dermatitis disease who will receive one treatment with the device and complete one in-person follow-up.
Participants with seborrheic dermatitis who will receive three treatments with the device and complete one in-person follow-up.
Participants with hair loss disease who will receive three treatments with the device and complete one in-person follow-up.